申请人:Actelion Pharmaceuticals Ltd.
公开号:US20140371204A1
公开(公告)日:2014-12-18
The invention relates to compounds of Formula (I) wherein ring A, X, (R
1
)
n
, R
2
, R
3
, R
4
, R
4′
, R
5
, n, and p are as described in the description; to pharmaceutically acceptable salts thereof, and to the use of such compounds as medicaments, especially as modulators of the CXCR3 receptor.
该发明涉及式(I)的化合物,其中环A、X、(R1)n、R2、R3、R4、R4'、R5、n和p如所述的描述;其药学上可接受的盐以及将这种化合物用作药物,特别是用作CXCR3受体调节剂。